Weichenberger Christian X, Afonine Pavel V, Kantardjieff Katherine, Rupp Bernhard
Center for Biomedicine, European Academy of Bozen/Bolzano (EURAC), Viale Druso 1, Bozen/Bolzano, I-39100 Südtirol/Alto Adige, Italy.
Physical Biosciences Division, Lawrence Berkeley National Laboratory (LBNL), 1 Cyclotron Road, Mail Stop 64R0121, Berkeley, CA 94720, USA.
Acta Crystallogr D Biol Crystallogr. 2015 May;71(Pt 5):1023-38. doi: 10.1107/S1399004715006045. Epub 2015 Apr 30.
The mother liquor from which a biomolecular crystal is grown will contain water, buffer molecules, native ligands and cofactors, crystallization precipitants and additives, various metal ions, and often small-molecule ligands or inhibitors. On average, about half the volume of a biomolecular crystal consists of this mother liquor, whose components form the disordered bulk solvent. Its scattering contributions can be exploited in initial phasing and must be included in crystal structure refinement as a bulk-solvent model. Concomitantly, distinct electron density originating from ordered solvent components must be correctly identified and represented as part of the atomic crystal structure model. Herein, are reviewed (i) probabilistic bulk-solvent content estimates, (ii) the use of bulk-solvent density modification in phase improvement, (iii) bulk-solvent models and refinement of bulk-solvent contributions and (iv) modelling and validation of ordered solvent constituents. A brief summary is provided of current tools for bulk-solvent analysis and refinement, as well as of modelling, refinement and analysis of ordered solvent components, including small-molecule ligands.
用于生长生物分子晶体的母液将含有水、缓冲分子、天然配体和辅因子、结晶沉淀剂和添加剂、各种金属离子,并且通常还含有小分子配体或抑制剂。平均而言,生物分子晶体约一半的体积由这种母液组成,其成分构成无序的大量溶剂。其散射贡献可用于初始相位确定,并且作为大量溶剂模型必须包含在晶体结构精修中。同时,源自有序溶剂成分的不同电子密度必须被正确识别并表示为原子晶体结构模型的一部分。本文综述了:(i)概率性大量溶剂含量估计;(ii)在相位改善中使用大量溶剂密度修正;(iii)大量溶剂模型以及大量溶剂贡献的精修;(iv)有序溶剂成分的建模与验证。还简要总结了当前用于大量溶剂分析和精修的工具,以及有序溶剂成分(包括小分子配体)的建模、精修和分析。